CN105920334A - 菊花痤疮膏 - Google Patents
菊花痤疮膏 Download PDFInfo
- Publication number
- CN105920334A CN105920334A CN201610220618.8A CN201610220618A CN105920334A CN 105920334 A CN105920334 A CN 105920334A CN 201610220618 A CN201610220618 A CN 201610220618A CN 105920334 A CN105920334 A CN 105920334A
- Authority
- CN
- China
- Prior art keywords
- parts
- acne
- skin
- chrysanthemum
- radix sophorae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 35
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 33
- 241000723353 Chrysanthemum Species 0.000 title claims abstract description 11
- 235000007516 Chrysanthemum Nutrition 0.000 title claims abstract description 11
- 239000006071 cream Substances 0.000 title abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000000052 vinegar Substances 0.000 claims abstract description 9
- 235000021419 vinegar Nutrition 0.000 claims abstract description 9
- 241000255791 Bombyx Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 16
- 239000011505 plaster Substances 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 7
- 241001161070 Calomela Species 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 4
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 abstract description 3
- 235000012907 honey Nutrition 0.000 abstract description 3
- 229940075397 calomel Drugs 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 241000124033 Salix Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 231100000241 scar Toxicity 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 14
- 206010017553 Furuncle Diseases 0.000 description 8
- 210000000589 cicatrix Anatomy 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 244000046101 Sophora japonica Species 0.000 description 5
- 235000010586 Sophora japonica Nutrition 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- DANYIYRPLHHOCZ-UHFFFAOYSA-N 5,7-dihydroxy-4'-methoxyflavone Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 DANYIYRPLHHOCZ-UHFFFAOYSA-N 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 201000004484 acute conjunctivitis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- HIPIENNKVJCMAP-UHFFFAOYSA-N chrysanthemol Chemical compound CC(C)=CC1C(CO)C1(C)C HIPIENNKVJCMAP-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000009498 luteolin Nutrition 0.000 description 2
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- JRHJXXLCNATYLS-SOOLLQOPSA-N (2s,6s,7ar)-2-[(2e,4e,6e,8e,10e,12e,14e,16e)-17-[(1r,4r)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14,16-octaen-2-yl]-4,4,7a-trimethyl-2,5,6,7-tetrahydro-1-benzofuran-6-ol Chemical compound C/C([C@@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-SOOLLQOPSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- LEEZDPXWPYCRRM-UHFFFAOYSA-N 3-hydroxy-beta-eudesmol Natural products C1CC(O)C(=C)C2CC(C(C)(O)C)CCC21C LEEZDPXWPYCRRM-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- IFXGCKRDLITNAU-JHSUYXJUSA-N Ambrosin Chemical compound C[C@H]1CC[C@H]2C(=C)C(=O)O[C@H]2[C@]2(C)C(=O)C=C[C@@H]12 IFXGCKRDLITNAU-JHSUYXJUSA-N 0.000 description 1
- IFXGCKRDLITNAU-QTRGNSQVSA-N Ambrosin Natural products O=C1C(=C)[C@H]2[C@H]([C@]3(C)C(=O)C=C[C@@H]3[C@H](C)CC2)O1 IFXGCKRDLITNAU-QTRGNSQVSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000256836 Apis Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 241001313857 Bletilla striata Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 229930008410 Chrysanthemol Natural products 0.000 description 1
- 229930185660 Chrysanthone Natural products 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 229930135083 Pyrenoline A+ Natural products 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000009962 acacetin Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- ZQFYXTQTVLEACQ-UHFFFAOYSA-N damsin Natural products CC1CCC2CC(=O)OC2C3(C)C1CCC3=O ZQFYXTQTVLEACQ-UHFFFAOYSA-N 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- -1 luteolin Glycoside Chemical class 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- DSNIKOZTDZBWKD-XMNJDQQWSA-N yejuhua lactone Chemical compound O([C@H]1C2C[C@H]([C@@](C3C1C(=CC3)C)(C)O)OC(=O)C)C(=O)C2(C1(C)C=C2)CC22C1[C@H]1OC(=O)C(=C)C1CC[C@@]2(C)O DSNIKOZTDZBWKD-XMNJDQQWSA-N 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种菊花痤疮膏,其配方中的原料及重量比分别是:野菊花4份、苦参3份、柳叶6份、金银花5份、蒲公英5份、白及3份、白僵蚕2份、陈醋45份、精制水15份、蜂蜜50份、轻粉7份、冰片7份。本发明所述各原料的用量和理化性质产生协同作用,从而达到治疗痤疮、见较快、治愈能力强的效果。本发明PH值与人体皮肤的PH值接近,对皮肤无刺激性;使用后明显感到舒适、柔软,无刺痛感,具有明显的治疗痤疮、护肤无疤痕的效果。
Description
技术领域
本发明涉及中药领域,具体涉及一种治疗痤疮、见较快、治愈能力强的菊花痤疮膏,对皮肤具有良好的治疗痤疮、护肤无疤痕的效果。
背景技术
痤疮,是毛囊皮脂腺单位的一种慢性炎症性皮肤病。主要好发于青少年,对青少年的心理和社交影响很大,但***后往往能自然减轻或痊愈。临床表现以好发于面部的粉刺、丘疹、脓疱、结节等多形性皮损为特点。痤疮的发生主要与皮脂分泌过多、毛囊皮脂腺导管堵塞、细菌感染和炎症反应等因素密切相关。进入***后人体内雄激素特别是睾酮的水平迅速升高,促进皮脂腺发育并产生大量皮脂。毛囊中多种微生物尤其是痤疮丙酸杆菌大量繁殖,痤疮丙酸杆菌产生的脂酶分解皮脂生成游离脂肪酸,最终诱导并加重炎症反应。痤疮的非炎症性皮损表现为开放性和闭合性粉刺。无论采用何种治疗方法,待皮损明显消退以后均应继续维持治疗,首选外用维A酸类药物,维持治疗6~12个月,必要时可联合过氧化苯甲酰。
发明内容
本发明的目的在于提供一种治疗痤疮、见较快、治愈能力强的菊花痤疮膏,对皮肤具有良好的治疗痤疮、护肤无疤痕的效果。
本发明采用了这样的技术方案:所述发明适用于敏感性肌肤的菊花痤疮膏,其配方中的原料及重量比分别是:野菊花4份、苦参3份、柳叶6份、金银花5份、蒲公英5份、白及3份、白僵蚕2份、陈醋45份、精制水15份、蜂蜜50份、轻粉7份、冰片7份。
本发明的重量配比是经过本发明人大量试验获得的,并且在长达2年的实际应用中证明,具有较为理想的治疗痤疮、护肤无疤痕的效果。
本发明中所述的原料:
野菊花:为菊科多年生草本植物野菊的头状花序,含挥发油01%~0.2%,油中含白菊醇、白菊酮,尚含dl-樟脑、β-3-蒈烯(β-3-carene)、桧烯及香草醇。此外,花中分离得野菊花内酯约0.1%,密蒙花甙约0.72%.另含木犀草素葡萄糖甙、菊红甙菊黄质、环氧叶黄素、木犀草素、野菊花酮(没药烷酮二醇),及野菊花醇、胡萝卜甙、豚草素、金合欢素、山俞酸甘油酯、棕榈酸等。野菊花含可广泛用于治疗疔疮痈肿、咽喉肿痛、风火赤眼、头痛眩晕等病证。同时又有很好的降压作用,可用于高血压病的辅助治疗。
苦参:(学名:Radix Sophorae flavescentis)为豆科苦参属的植物。别名:苦骨、地槐、水槐、菟槐、骄槐、野槐或白茎。中药苦参为多年生落叶亚灌木植物苦参的根。在中国各地均产。每年春秋两季采收入药用。【性味】味苦;性寒。【归经】肝;肾;大肠;小肠经;膀胱;心经;膀胱经。功能主治:清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治滴虫性***炎。苦参具有抗菌消炎的作用,对痤疮杆菌、金黄色葡萄球菌、大肠杆菌均有抑制作用,能利尿、抗过敏、镇痛、平喘、祛痰。
柳叶:清热解毒,解毒透疹,利尿通淋。治痧疹透发不畅,白浊,疔疮疖肿,乳腺炎,甲状腺肿,丹毒,烫伤,牙痛。
金银花:【性味归经】味甘;寒。归肺;胃经。【功效主治】清热解毒。温病发热;热毒血痢;痈肿疔疮;喉痹及多种感染性疾病。
蒲公英:属菊科多年生草本植物。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值。【性味功能】:甘,微苦,寒。清热解毒,消肿散结。【主治】:上呼吸道感染,眼结膜炎,流行性腮腺炎,高血糖,乳痈肿痛,胃炎,痢疾,肝炎,胆襄炎,急性阑尾炎,***,***,痈疖疔疮,咽炎,治急性乳腺炎,淋巴腺炎,瘰疠,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎、***。
白及:兰科植物白及Bletilla striata(Thund.)Reichb.f.的干燥块茎。【性味归经】:苦、甘、涩,微寒。归肺、肝、胃经。补肺,止血,消肿,生肌,敛疮。功能主治:收敛止血,消肿生肌。用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。
白僵蚕:祛风解痉,化痰散结。主治:惊痫抽搐,中风口眼歪斜,破伤风,偏正头痛,瘰疠痰核,痄腮,咽喉肿痛,目赤流泪,齿痛牙疳,女子崩带,疔疮肿毒,风疹瘙痒;风疮瘾疹,丹毒,乳腺炎。
陈醋:酿成后存放较久的醋。浓褐色,液态清亮,醋味醇厚,具有少沉淀,贮放时间长,不易变质等特点。主要原料:高粱,麸皮,水。主要功效:散瘀,止血,解毒,杀虫。
精制水:将通常水蒸馏或通过离子交换树脂精制的水。性状本品为无色透明液体,无气味,无味。pH 5.0~7.0。精制水是各种化工生产所必需的原料。
蜂蜜:是昆虫蜜蜂从开花植物的花中采得的花蜜在蜂巢中酿制的蜜。蜂蜜的成分除了葡萄糖、果糖之种还含有各种维生素、矿物质和氨基酸。1千克的蜂蜜含有2940卡的热量。蜂蜜是糖的过饱和溶液,低温时会产生结晶,生成结晶的是葡萄糖,不产生结晶的部分主要是果糖。蜂蜜是一种营养丰富的天然滋养食品,也是最常用的滋补品之一。据分析,含有与人体血清浓度相近的多种无机盐和维生素、铁、钙、铜、锰、钾、磷等多种有机酸和有益人体健康的微量元素,以及果糖、葡萄糖、淀粉酶、氧化酶、还原酶等,具有滋养、润燥、解毒、美白养颜、润肠通便之功效。
轻粉:为氯化亚汞(Hg2Cl2)。外用具有杀虫,攻毒,敛疮之功效;内服具有祛痰消积,逐水通便之功效。外治用于疥疮,顽癣,臁疮,梅毒,疮疡,湿疹;内服用于痰涎积滞,水肿臌胀,二便不利。
冰片:【主要成分】:本品为从龙脑香的树脂和挥发油中取得的结晶,是近乎纯粹的右旋龙脑。【功能与主治】通诸窍,散郁火,去翳明目,消肿止痛。治中风口噤,热病神昏,惊痫痰迷,气闭耳聋,喉痹,口疮,中耳炎,痈肿,痔疮,目亦翳膜,蛲虫病。
本发明所述各原料的用量和理化性质产生协调作用,积极效果在于:治疗痤疮、见较快、治愈能力强;PH值与人体皮肤的PH值接近,对皮肤无刺激性;使用后明显感到舒适、柔软,无刺痛感,具有明显的治疗痤疮、护肤无疤痕的效果。
本发明的使用效果实验对比:地址:河南省登封市东关街“某知名品牌美容健身机构”。
第一组:参与实验人数183名,均为某知名品牌美容健身机构女性顾客,年龄18-36岁。使用某企业著名品牌痤疮膏,使用周期为1个月,平均每人每日使用1-2次。实验结果:满意率65.4%;满意标准:使用后明显感到舒适、柔软,无刺痛感,具有明显的消炎护肤效果。
第二组:参与实验人数177名,均为某知名品牌美容健身机构女性顾客,年龄18-42岁。使用本发明所述的菊花痤疮膏,使用方法是:擦拭于过敏肌肤或有痤疮部位肌肤。使用周期为1个月,平均每人每日使用1-2次。实验结果:满意率87.2%;满意标准:对皮肤无刺激性,使用后明显感到舒适、柔软,无刺痛感,具有明显的治疗痤疮、护肤无疤痕的效果。
实验对照结果:本发明所述的菊花痤疮膏,对皮肤无刺激性,使用后明显感到舒适、柔软,无刺痛感,具有明显的治疗痤疮、护肤无疤痕的效果。
具体实施方式
所述菊花痤疮膏,其配方中的原料及重量比分别是:野菊花4份、苦参3份、柳叶6份、金银花5份、蒲公英5份、白及3份、白僵蚕2份、陈醋45份、精制水15份、蜂蜜50份、轻粉7份、冰片7份。其制备方法是:
步骤一:将野菊花、苦参、金银花、白及、柳叶、蒲公英、白僵蚕等中药研磨,过100~200目筛;
步骤二:将陈醋、精制水、蜂蜜加热,待凉后兑入步骤(一)药面中,搅拌均匀直至成为膏状,然后再将轻粉、冰片研细兑入搅匀即成成品,按一定剂量分装即可。
Claims (2)
1.一种菊花痤疮膏,其特征在于,配方中的原料及重量比分别是:野菊花4份、苦参3份、柳叶6份、金银花5份、蒲公英5份、白及3份、白僵蚕2份、陈醋45份、精制水15份、蜂蜜50份、轻粉7份、冰片7份。
2.按照权利要求1所述的痤疮膏,其特征在于,所述菊花痤疮膏的制备方法是:
步骤一:将野菊花、苦参、金银花、白及、柳叶、蒲公英、白僵蚕等中药研磨,过100~200目筛;
步骤二:将陈醋、精制水、蜂蜜加热,待凉后兑入步骤(一)药面中,搅拌均匀直至成为膏状,然后再将轻粉、冰片研细兑入搅匀即成成品,按一定剂量分装即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610220618.8A CN105920334A (zh) | 2016-03-29 | 2016-03-29 | 菊花痤疮膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610220618.8A CN105920334A (zh) | 2016-03-29 | 2016-03-29 | 菊花痤疮膏 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105920334A true CN105920334A (zh) | 2016-09-07 |
Family
ID=56840533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610220618.8A Pending CN105920334A (zh) | 2016-03-29 | 2016-03-29 | 菊花痤疮膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105920334A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106822591A (zh) * | 2017-03-09 | 2017-06-13 | 屈国香 | 复方痤疮膏 |
CN108294980A (zh) * | 2018-02-07 | 2018-07-20 | 嘉善县圣康生物科技有限公司 | 一种中药祛痘护肤面霜 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259381A (zh) * | 1999-12-16 | 2000-07-12 | 傅广和 | 菊花痤疮膏 |
CN101804163A (zh) * | 2010-04-21 | 2010-08-18 | 黄泳葛 | 一组专一的祛痘药物和治疗方法 |
CN102145133A (zh) * | 2011-03-30 | 2011-08-10 | 黄泳葛 | 三位一体祛痘法 |
-
2016
- 2016-03-29 CN CN201610220618.8A patent/CN105920334A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1259381A (zh) * | 1999-12-16 | 2000-07-12 | 傅广和 | 菊花痤疮膏 |
CN101804163A (zh) * | 2010-04-21 | 2010-08-18 | 黄泳葛 | 一组专一的祛痘药物和治疗方法 |
CN102145133A (zh) * | 2011-03-30 | 2011-08-10 | 黄泳葛 | 三位一体祛痘法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106822591A (zh) * | 2017-03-09 | 2017-06-13 | 屈国香 | 复方痤疮膏 |
CN108294980A (zh) * | 2018-02-07 | 2018-07-20 | 嘉善县圣康生物科技有限公司 | 一种中药祛痘护肤面霜 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105030621A (zh) | 一种保湿祛痘爽肤水及其制备方法 | |
CN102139030A (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN105078829A (zh) | 一种中药祛痘面霜及其制备方法 | |
CN109364207A (zh) | 一种治疗和缓解痤疮的组合物及制备方法与应用 | |
CN105030620A (zh) | 一种保湿祛痘洗面奶及其制备方法 | |
CN107669935A (zh) | 一种中药抗过敏美容面膜及其制备方法 | |
CN105920334A (zh) | 菊花痤疮膏 | |
CN104873446A (zh) | 一种含肉桂油的牙膏 | |
CN105412415A (zh) | 祛痤疮的药物组合物 | |
CN105748374A (zh) | 中药嫩肤养颜美容液 | |
CN103007034B (zh) | 用于治疗ⅱ度烧伤残余创面的中药组合物及制备方法 | |
CN105031170A (zh) | 一种保健足浴粉及其制备方法 | |
CN104922011A (zh) | 纯中药美白护肤乳液 | |
CN109157426A (zh) | 一种含有4-松油醇的皮肤护理剂及其制备方法 | |
CN106176385A (zh) | 治疗痤疮、疤痕的化妆品 | |
CN107029044A (zh) | 速效痤疮药 | |
CN105456708A (zh) | 一种用于治疗***炎的药物及其制备方法 | |
CN105250815A (zh) | 一种用于治疗寻常型痤疮的中药组合物及其制备方法 | |
CN107441387A (zh) | 一种用于治疗湿热体质痤疮的中药方剂 | |
CN104888195A (zh) | 一种用于促进创伤愈合的植物精华肽组合物 | |
CN103301336B (zh) | 一种保湿防皴裂护肤膏及其制备方法 | |
CN105168779A (zh) | 一种治疗皮肤过敏的药剂 | |
CN104887808A (zh) | 一种治疗牙周炎的中药制剂 | |
CN104491683A (zh) | 一种治疗扁平疣的中药组合物及其制备方法 | |
CN111671715A (zh) | 一种祛痘组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160907 |
|
WD01 | Invention patent application deemed withdrawn after publication |